Methotrexate vs Moxetumomab Pasudotox

## Methotrexate vs Moxetumomab Pasudotox: Overview

This comparison examines the pharmacological differences between **Methotrexate** and **Moxetumomab Pasudotox**.

## Mechanism of Action

**Methotrexate**: Dihydrofolate reductase inhibitor.

## Pharmacokinetics

**Half-life**: Methotrexate — 3-10 hours; Moxetumomab Pasudotox — N/A.

## Chemical Properties

**Molecular Formula**: Methotrexate — C20H22N8O5; Moxetumomab Pasudotox — N/A.

**Molecular Weight**: Methotrexate — 454.4400 g/mol; Moxetumomab Pasudotox — N/A.

**Type**: Methotrexate — Small molecule; Moxetumomab Pasudotox — Antibody drug conjugate.